Sign In
Buy INCY
$119.80
-0.800 (-0.663%)
At Close: Aug 05, 2026
Incyte's (INCY) Itacitinib Fails in Late-Stage GVHD Study
10:01am, Friday, 03'rd Jan 2020
Incyte (INCY) fails to meet goals in the phase III study on itacitinib for the treatment of first-line acute GVHD.
Leading Biotech Stock Crashes After Promising Drug Fails Late-Stage Test
05:29pm, Thursday, 02'nd Jan 2020
Incyte stock crashed late Thursday after the biotech company's treatment for never-before-treated patients with graft vs. host disease, a transplant complication, failed in a study.
Incyte stock slammed after study fails to hit goal
04:40pm, Thursday, 02'nd Jan 2020
Incyte Corp. INCY, -1.55% shares fell more than 12% in after-hours trading Thursday after the company revealed that a phase-3 study of a drug failed to reach its goal.
A $20 Billion Sweet Spot in Biotech
08:00am, Saturday, 28'th Dec 2019
Few biotech companies ever reach that valuation, and if they do, you should snap them up for your portfolio.
Incyte (INCY) Stock Moves -0.44%: What You Should Know
05:50pm, Friday, 27'th Dec 2019
In the latest trading session, Incyte (INCY) closed at $88.39, marking a -0.44% move from the previous day.
Inphi And Vertex Flatten Out; Incyte Gets Support
04:43pm, Friday, 27'th Dec 2019
Markets Take A Pause; Stock Setups Continue.
Incyte (INCY) Surges 44% YTD on Jakafi's Strong Performance
09:13am, Thursday, 26'th Dec 2019
Incyte (INCY) outperforms the industry year to date on strong Jakafi sales.
Has Incyte (INCY) Outpaced Other Medical Stocks This Year?
11:30am, Tuesday, 24'th Dec 2019
Is (INCY) Outperforming Other Medical Stocks This Year?
Biotech Stock Outlook: M&A Activity Retains Growth Streak
10:18am, Thursday, 19'th Dec 2019
Biotech Stock Outlook: M&A Activity Retains Growth Streak
Here's Why Momentum Investors Will Love Incyte (INCY)
12:00pm, Monday, 16'th Dec 2019
Does Incyte (INCY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Moving Average Crossover Alert: Incyte
05:13am, Tuesday, 10'th Dec 2019
Incyte is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
9 Most Overbought Stocks In The S&P 500
10:35am, Monday, 09'th Dec 2019
While value investors look for stocks that have become priced too low or high based on fundamental metrics such as earnings, revenue and debt, technical traders base their buys and sells off of recent
Incyte's NDA For Pemigatinib Drug Accepted, But It Is Not A One Hit Wonder
11:12am, Wednesday, 04'th Dec 2019
Incyte's NDA For Pemigatinib Drug Accepted, But It Is Not A One Hit Wonder
Why Incyte Stock Climbed 12.2% in November
09:56am, Wednesday, 04'th Dec 2019
Strong sales for the company's main drug and potential new applications and treatments have pushed the pharma stock up 48% in 2019.
Why You Should Keep An Eye On These 5 Leading Health Care Stocks
09:00am, Tuesday, 03'rd Dec 2019
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
